The future of the global cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets. The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of the
most promising, high-growth opportunities for the cardiac rhythm management
devices market by product type (cardiac pacemakers, defibrillators, and cardiac
resynchronization therapy devices), end use (hospitals & clinics,
ambulatory surgery centers, and others), and region (North America, Europe,
Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, cardiac
pacemakers, defibrillators, and cardiac resynchronization therapy devices are
the major segments of cardiac rhythm management devices market by application
type. Lucintel forecasts that defibrillators will remain the largest segment
over the forecast period due to the rising prevalence of out-of-hospital
cardiac arrests.
Within this market,
hospitals and clinics is expected to remain the largest segment.
North America will
remain the largest region due to surge in elderly population and presence of
advanced healthcare system in the region.
Physio-Control,
Medtronic, Abbott, Boston Scientific Corporation, Schiller, Koninklijke
Philips, Biotronik, Progetti, Zoll Medical Corporation, and Livanova are the
major suppliers in the cardiac rhythm management devices market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment